The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.20
Bid: 47.20
Ask: 47.95
Change: -0.50 (-1.05%)
Spread: 0.75 (1.589%)
Open: 47.90
High: 48.00
Low: 47.20
Prev. Close: 47.70
OMU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

12 Mar 2024 07:00

RNS Number : 4250G
Old Mutual Limited
12 March 2024
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

LSE Share Code: OMU

NSX Share Code: OMM

MSE Share Code: OMU

ZSE Share Code: OMU

("Old Mutual" or "Company" or "Group")

 

Ref: 14/24

12 March 2024

 

OLD MUTUAL TRADING STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

 

Investors are advised that Old Mutual is currently in the process of finalising its results for the year ended 31 December 2023 ("current period"), which will be released on the Stock Exchange News Service of the JSE Limited on Wednesday, 27 March 2024. The ranges provided in this trading statement are relative to the results for the year ended 31 December 2022 ("comparative period") prepared on an IFRS 17 basis.

This trading statement provides an indication of a range for headline earnings per ordinary share ("HEPS") and earnings attributable to equity holders of the Group per ordinary share ("EPS") in terms of paragraph 3.4(b) of the JSE Limited Listings Requirements compared to the comparative period.

Old Mutual recorded robust results from operations ("RFO") growth due to strong operational performance underpinned by exceptional growth in new business and value of new business as we continue to gain market share across our segments.

Adjusted headline earnings ("AHE") growth was further bolstered by increased shareholder investment returns as a result of increased interest rates and a recovery in equity markets.

We exclude the Zimbabwe profits from AHE as the economy is currently hyperinflationary resulting in earnings volatility. The main contributor to the higher level of growth in headline earnings relative to AHE is higher shareholder portfolio profits in the Zimbabwean business.

Investors are advised that the Group's key profit measures are expected to be within the ranges outlined below:

Key profit measures

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

31 December 2023

IFRS17 unaudited results for the year ended

31 December 2022

RFO ¹

6% to 26%

7 749 to 9 211

7 310

AHE 2

13% to 33%

5 481 to 6 451

4 850

Adjusted headline earnings per share ("AHEPS") (cents) 3

14% to 34%

121.3 to 142.6

106.4

Headline earnings

16% to 36%

6 792 to 7 963

5 855

HEPS (cents)

18% to 38%

152.5 to 178.3

129.2

IFRS profit after tax attributable to equity holders of the parent

25% to 45%

6 540 to 7 586

5 232

Basic EPS (cents)

27% to 47%

146.7 to 169.8

115.5

 

1 RFO is the primary measure of the operating business performance of the Group's segments.

2 AHE is the Group's primary profit metric.

3 HEPS is defined as AHE divided by the weighted average number of ordinary shares adjusted to reflect the Group's B-BBEE shares.

 

The current period results are prepared on an IFRS 17 basis whereas the results for the comparative period were prepared on an IFRS 4 basis. The release of our 30 June 2023 interim results was accompanied by an IFRS 17 bridging pack which provided the comparative period numbers on both an IFRS 4 and IFRS 17 basis. It is not expected that results will differ by 20% or more when compared to previously disclosed comparative period results under IFRS 4 which are disclosed in Annexure A hereto.

 

The financial information in this trading statement is the responsibility of the Old Mutual Limited Board of Directors and has not been reviewed or reported on by the Group's external auditors.

Sandton

 

Sponsors

JSE

Tamela Holdings (Proprietary) Limited

Namibia

PSG Wealth Management (Namibia) (Proprietary) Limited

Zimbabwe

Imara Capital Zimbabwe plc

Malawi

Stockbrokers Malawi Limited

 

 

Enquiries

Investor Relations

Langa Manqele

Head of Investor Relations

M: +27 82 295 9840

E: investorrelations@oldmutual.com

Communications

Wendy Tlou

Interim Chief Communications Officer

M: +27 83 301 9663

E: oldmutualnews@oldmutual.com

 

Notes to Editors

About Old Mutual Limited

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key market segments in 14 countries. Old Mutual's primary operations are in Africa, and it has a niche business in China. With over 178 years of heritage across sub-Saharan Africa, Old Mutual is a crucial part of the communities it serves as well as broader society on the continent.

 

For further information on Old Mutual and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

 

 

 

Annexure A

 

 

31 December 2022

Key profit measures

(R million unless stated otherwise)

IFRS17 unaudited results for the year ended

IFRS 4

published results for the year ended

RFO

7 310

8 743

AHE

4 850

6 371

AHEPS (cents)

106.4

139.8

Headline earnings

5 855

7 948

HEPS (cents)

129.2

180.1

IFRS profit after tax attributable to equity holders of the parent

5 232

7 325

Basic EPS (cents)

115.5

166.0

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUAARRSNUOAUR
Date   Source Headline
13th Feb 202411:00 amRNSForm 8.3 - Mondi Plc
2nd Jan 20243:00 pmRNSDealings in securities on behalf of Share Trusts
27th Dec 20233:00 pmRNSDealings in securities on behalf of ESIS
21st Dec 20233:00 pmRNSChange of the JSE Equity Sponsor
20th Dec 20233:30 pmRNSDealings in securities on behalf of ESIS
19th Dec 20233:30 pmRNSSecurities dealings on behalf of ESIS
12th Dec 20233:45 pmRNSChange in JSE equity sponsor
5th Dec 20233:45 pmRNSDirectorate Change
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
30th Nov 202311:00 amRNSDirector/PDMR Shareholding
22nd Nov 20238:00 amRNSOld Mutual Limited Voluntary Operating Update
9th Nov 20233:00 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSDirector/PDMR Shareholding
26th Oct 20234:30 pmRNSOld Mutual Share Repurchase programme
25th Oct 20234:30 pmRNSDealings in securities on behalf of ESIS
20th Oct 20234:00 pmRNSDealings in securities on behalf of ESIS
17th Oct 20232:30 pmRNSDealing in securities on behalf of ESIS
3rd Oct 20239:00 amRNSFinalisation and dividend currency equivalents
27th Sep 20237:00 amRNSUnaudited Interim Results and Dividend Declaration
13th Sep 20237:00 amRNSVoluntary Trading Statement
28th Jul 20237:00 amRNSInvestor update and release of information
30th May 202310:00 amRNSOld Mutual Share Repurchase Programme
30th May 20237:00 amRNSResult of AGM
26th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
25th May 202311:40 amRNSVoluntary Operating Update
18th May 20231:30 pmRNSForm 8.3 - Mediclinic International plc
11th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
4th May 20231:45 pmRNSForm 8.3 - Mediclinic International plc
27th Apr 20232:00 pmRNSForm 8.3 - Mediclinic International plc
25th Apr 20233:30 pmRNSNotice of AGM and no change statement
24th Apr 202311:00 amRNSDirector/PDMR Shareholding
21st Apr 20231:45 pmRNSForm 8.3 - [Mediclinic International plc]
19th Apr 20234:00 pmRNSDirector/PDMR Shareholding
14th Apr 202311:00 amRNSRelease of Integrated Report & Investor Engagement
13th Apr 202312:30 pmRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSForm 8.3 - [Mediclinic International plc]
6th Apr 20234:40 pmRNSDirector/PDMR Shareholding
6th Apr 20232:45 pmRNSDealings in securities on behalf of ESIS
6th Apr 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Apr 202311:00 amRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20232:00 pmRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20231:00 pmRNSDealings in securities on behalf of ESOP
4th Apr 20239:00 amRNSOML BEE certificate and annual compliance report
31st Mar 20232:30 pmRNSDealings in Securities on behalf of Share Trusts
30th Mar 202312:15 pmRNSForm 8.3 - [Mediclinic International plc]
29th Mar 20232:30 pmRNSDealings in securities on behalf of share trusts
27th Mar 20234:15 pmRNSDealings in securities on behalf of a share trust
24th Mar 20237:00 amRNSNo change statement
22nd Mar 20238:00 amRNSFINALISATION AND DIVIDEND CURRENCY EQUIVALENTS
17th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.